Positron emission tomography/computed tomography (PET/CT) in children

Pediatric Annals

Volumn 37, Issue 6, 2008, Pages 404-412

  Shore, Richard M ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; AMMONIA N 13; ANTINEOPLASTIC AGENT; CARBON 11; EPHEDRINE DERIVATIVE; FLUAZAMIL C 11; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GRANULOCYTE COLONY STIMULATING FACTOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 124; LEVODOPA; METHIONINE C 11; N METHYLTRYPTOPHAN; NITROGEN 13; OXYGEN 15; STEROID; WATER O 15;

ALZHEIMER DISEASE; BONE METASTASIS; BRAIN MAPPING; BRAIN TUMOR; CAMERA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; EPILEPSY; EPILEPTIC FOCUS; HUMAN; HUNTINGTON CHOREA; HYPERINSULINISM; LUNG METASTASIS; LYMPHOMA; NEURAL CREST; NEUROBLASTOMA; NEUROFIBROMATOSIS; NEUROIMAGING; PANCREAS ISLET DISEASE; PEDIATRICS; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

CHILD; CHILD WELFARE; EPILEPSY; FEMALE; HUMANS; MALE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 47549099238     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20080601-13     Document Type: Review

References (12)

1. Bar-Sever Z, Keidar Z, Ben-Barak A, et al. The incremental value of 18F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging. 2007;34(5):630-637.
2. Charron M, ed. Practical Pediatric PET Imaging. New York: Springer Science Business Media; 2006.
3. Ferner RE, Golding JF, Smith M, Calonje E, et al. [18F]2-fluoro-2-deoxy- D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol. 2008;19(2):390-394.
4. Hermann S, Wormanns D, Pixberg M, et al. Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin. 2005;44(1):1-7.
5. Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol. 2006;36(6):524-531.
6. Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol. 2004;34(3):190-198.
7. Jadvar H, Alavi A, Mavi A, Shulkin BL. PET in pediatric diseases. Radiol Clin North Am. 2005;43(1):135-152.
8. Patil S, Biassoni L, Borgwardt L. Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med. 2007;37(5):357-381.
9. Rhodes MM, Delbeke D, Whitlock JA, et al. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 2006;28(5):300-306.
10. Rini JN, Núñez R, Nichols K, et al. Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease. Pediatr Radiol. 2005;35(2):169-178.
11. Sharp SE, Shulkin BL, Furman WL, Gelfand MJ. I-123-MIBG scintigraphy and [F-18]FDG PET in neurobastoma: comparative imaging at diagnosis and follow-up. Pediatr Radiol 2008;38S2:S301.
12. Son JM, Ahn MI, Cho KD, Yoo J, Park YH. Varying degrees of FDG uptake in multiple benign neurofibromas on PET/CT. Br J Radiol. 2007;80(957):e222-e226.